Ausdal Financial Partners’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$293K Sell
26,288
-2,500
-9% -$30.4K 0.01% 836
2026
Q1
$402K Buy
28,788
+5,398
+23% +$75.7K 0.02% 664
2025
Q4
$337K Sell
23,390
-1,367
-6% -$20.6K 0.02% 678
2025
Q3
$394K Sell
24,757
-22,726
-48% -$374K 0.02% 628
2025
Q2
$840K Sell
47,483
-176,774
-79% -$3.44M 0.06% 298
2025
Q1
$4.67M Buy
+224,257
New +$4.25M 0.35% 59

Other funds holding BTAL

Ausdal Financial Partners's BTAL Position: Q2 2026 in Review

Ausdal Financial Partners reduced its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 8.7% in Q2 2026, selling an estimated $30.4K and leaving 26,288 shares worth $293K. The position accounts for 0.01% of the portfolio, ranked #836.

Ausdal Financial Partners first reported a position in BTAL in Q1 2025 and has held it in 6 quarters since. The position peaked at $4.67M in Q1 2025. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.

  • Ausdal Financial Partners held 26,288 shares of AGF US Market Neutral Anti-Beta Fund worth $293K as of Q2 2026.
  • Ausdal Financial Partners sold 2,500 AGF US Market Neutral Anti-Beta Fund shares in Q2 2026, an estimated $30.4K.
  • AGF US Market Neutral Anti-Beta Fund made up 0.01% of Ausdal Financial Partners's portfolio in Q2 2026, its #836 holding.
  • Ausdal Financial Partners first reported a position in AGF US Market Neutral Anti-Beta Fund in Q1 2025 and has held it in 6 quarters since.
  • Ausdal Financial Partners's AGF US Market Neutral Anti-Beta Fund position peaked at $4.67M in Q1 2025.
  • 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.

Based on Ausdal Financial Partners's 13F filing for Q2 2026, filed 14 Aug 2026.